Invitation to Presentation of BioInvent’s Fourth Quarter Report 2019 on February 27, 2020

24. Februar 2020 INDIZES WEUR

BioInvent International AB (OMXS: BINV) is a clinical stage company that discovers and develops novel and first-in-class immuno …
(Orginal – Story lesen…)

Tags: atx cac ftse ibex omxs wig-20

You may also like...